N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site
- PMID: 20053750
- PMCID: PMC2826034
- DOI: 10.1128/JVI.02331-09
N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site
Abstract
The hemagglutinin-neuraminidase (HN) glycoprotein plays a critical role in parainfluenza virus replication. We recently found that in addition to the catalytic binding site, HN of human parainfluenza virus type 1 (hPIV-1) may have a second receptor-binding site covered by an N-linked glycan at residue 173, which is near the region of the second receptor-binding site identified in Newcastle disease virus (NDV) HN (I. A. Alymova, G. Taylor, V. P. Mishin, M. Watanabe, K. G. Murti, K. Boyd, P. Chand, Y. S. Babu, and A. Portner, J. Virol. 82:8400-8410, 2008). Sequence analysis and superposition of the NDV and hPIV-3 HN dimer structures revealed that, similar to what was seen in hPIV-1, the N-linked glycan at residue 523 on hPIV-3 HN may cover a second receptor-binding site. Removal of this N-linked glycosylation site by an Asn-to-Asp substitution at residue 523 (N523D) changed the spectrum of the mutant virus's receptor specificity, delayed its elution from both turkey and chicken red blood cells, reduced mutant sensitivity (by about half) to the selective HN inhibitor BCX 2855 in hemagglutination inhibition tests, and slowed its growth in LLC-MK(2) cells. The neuraminidase activity of the mutant and its sensitivity to BCX 2855 in neuraminidase inhibition assays did not change, indicating that the mutation did not affect the virus's catalytic-binding site and that all observed effects were caused by the exposure of the purported second receptor-binding site. Our data are consistent with the idea that, similar to the case for hPIV-1, the N-linked glycan shields a second receptor-binding site on hPIV-3 HN.
Figures




Similar articles
-
Loss of the N-linked glycan at residue 173 of human parainfluenza virus type 1 hemagglutinin-neuraminidase exposes a second receptor-binding site.J Virol. 2008 Sep;82(17):8400-10. doi: 10.1128/JVI.00474-08. Epub 2008 Jun 25. J Virol. 2008. PMID: 18579600 Free PMC article.
-
Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein.J Virol. 2006 Sep;80(18):9009-16. doi: 10.1128/JVI.00969-06. J Virol. 2006. PMID: 16940513 Free PMC article.
-
Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites.J Virol. 2004 Dec;78(24):13911-9. doi: 10.1128/JVI.78.24.13911-13919.2004. J Virol. 2004. PMID: 15564499 Free PMC article.
-
A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism.J Virol. 2007 Apr;81(7):3216-28. doi: 10.1128/JVI.02617-06. Epub 2007 Jan 17. J Virol. 2007. PMID: 17229690 Free PMC article.
-
New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase.Antiviral Res. 2019 Jul;167:89-97. doi: 10.1016/j.antiviral.2019.04.001. Epub 2019 Apr 3. Antiviral Res. 2019. PMID: 30951732 Review.
Cited by
-
Inhibition of primary clinical isolates of human parainfluenza virus by DAS181 in cell culture and in a cotton rat model.Antiviral Res. 2013 Nov;100(2):562-6. doi: 10.1016/j.antiviral.2013.09.014. Epub 2013 Sep 27. Antiviral Res. 2013. PMID: 24076357 Free PMC article.
-
Epidemiological and molecular characteristics of human parainfluenza virus in southern China during 2016-2020.Virol Sin. 2025 Apr;40(2):157-165. doi: 10.1016/j.virs.2025.03.004. Epub 2025 Mar 18. Virol Sin. 2025. PMID: 40112925 Free PMC article.
-
A dual drug regimen synergistically blocks human parainfluenza virus infection.Sci Rep. 2016 Apr 7;6:24138. doi: 10.1038/srep24138. Sci Rep. 2016. PMID: 27053240 Free PMC article.
-
Addicted to sugar: roles of glycans in the order Mononegavirales.Glycobiology. 2019 Jan 1;29(1):2-21. doi: 10.1093/glycob/cwy053. Glycobiology. 2019. PMID: 29878112 Free PMC article.
-
Genetic Characteristics of Human Parainfluenza Virus Types 1-4 From Patients With Clinical Respiratory Tract Infection in China.Front Microbiol. 2021 Jul 15;12:679246. doi: 10.3389/fmicb.2021.679246. eCollection 2021. Front Microbiol. 2021. PMID: 34335501 Free PMC article.
References
-
- Alymova, I. V., G. Taylor, V. P. Mishin, M. Watanabe, K. G. Murti, K. Boyd, P. Chand, Y. S. Babu, and A. Portner. 2008. Loss of the N-linked glycan at residue 173 on human parainfluenza virus type 1 hemagglutinin-neuraminidase exposes a second receptor-binding site. J. Virol. 82:8400-8410. - PMC - PubMed
-
- Alymova, I. V., G. Taylor, T. Takimoto, T. H. Lin, P. Chand, Y. S. Babu, C. Li, X. Xiong, and A. Portner. 2004. Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo. Antimicrob. Agents Chemother. 48:1495-1502. - PMC - PubMed
-
- Crennell, S., T. Takimoto, A. Portner, and G. Taylor. 2000. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat. Struct. Biol. 7:1068-1074. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources